These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18045970)

  • 1. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
    Lob S; Konigsrainer A; Schafer R; Rammensee HG; Opelz G; Terness P
    Blood; 2008 Feb; 111(4):2152-4. PubMed ID: 18045970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
    Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
    Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
    Qian F; Villella J; Wallace PK; Mhawech-Fauceglia P; Tario JD; Andrews C; Matsuzaki J; Valmori D; Ayyoub M; Frederick PJ; Beck A; Liao J; Cheney R; Moysich K; Lele S; Shrikant P; Old LJ; Odunsi K
    Cancer Res; 2009 Jul; 69(13):5498-504. PubMed ID: 19491279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.
    Metz R; Duhadaway JB; Kamasani U; Laury-Kleintop L; Muller AJ; Prendergast GC
    Cancer Res; 2007 Aug; 67(15):7082-7. PubMed ID: 17671174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells.
    Sun T; Chen XH; Tang ZD; Cai J; Wang XY; Wang SC; Li ZL
    Mol Cell Biochem; 2010 Sep; 342(1-2):29-34. PubMed ID: 20424892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
    Qian F; Liao J; Villella J; Edwards R; Kalinski P; Lele S; Shrikant P; Odunsi K
    Cancer Immunol Immunother; 2012 Nov; 61(11):2013-20. PubMed ID: 22527253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
    Hou DY; Muller AJ; Sharma MD; DuHadaway J; Banerjee T; Johnson M; Mellor AL; Prendergast GC; Munn DH
    Cancer Res; 2007 Jan; 67(2):792-801. PubMed ID: 17234791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
    Hwang SL; Chung NP; Chan JK; Lin CL
    Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan.
    Yuasa HJ; Ball HJ; Austin CJ; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):10-5. PubMed ID: 20399882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
    Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
    Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
    Opitz CA; Litzenburger UM; Opitz U; Sahm F; Ochs K; Lutz C; Wick W; Platten M
    PLoS One; 2011; 6(5):e19823. PubMed ID: 21625531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of indoleamine 2,3-dioxygenase by stereoisomers of 1-methyl tryptophan in an experimental graft-versus-tumor model.
    Lim JY; Lee SE; Park G; Choi EY; Min CK
    Exp Hematol; 2014 Oct; 42(10):862-6.e3. PubMed ID: 24971697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
    El Kholy NM; Sallam MM; Ahmed MB; Sallam RM; Asfour IA; Hammouda JA; Habib HZ; Abu-Zahra F
    Med Oncol; 2011 Mar; 28(1):270-8. PubMed ID: 20300979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
    Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
    Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of IDO1, D-1-methyl-tryptophan (D-1MT), effectively increased EpCAM/CD3-bispecific BiTE antibody MT110 efficacy against IDO1
    Hong R; Zhou Y; Tian X; Wang L; Wu X
    Int Immunopharmacol; 2018 Jan; 54():118-124. PubMed ID: 29128855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.
    Nakamura N; Hara T; Shimizu M; Mabuchi R; Nagano J; Ohno T; Kochi T; Kubota M; Shirakami Y; Goto N; Ito H; Saito K; Tanaka T; Moriwaki H; Tsurumi H
    Int J Hematol; 2015 Sep; 102(3):327-34. PubMed ID: 26243621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.
    Yuasa HJ; Ball HJ
    J Mol Evol; 2011 Feb; 72(2):160-8. PubMed ID: 21170645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion.
    Liu M; Li Z; Yao W; Zeng X; Wang L; Cheng J; Ma B; Zhang R; Min W; Wang H
    Mol Med Rep; 2020 Jan; 21(1):445-453. PubMed ID: 31746428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.